Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

The global radiation oncology market size was US$ 7.7 billion in 2021. The global radiation oncology market size is estimated to reach US$ 15.1 billion by 2030, growing at a compound annual growth ...

OneOncology, a physician-led national platform supporting independent oncology practices, and its Monterey-based partner ...

The Phase 1/2a trial is a two-part, single-arm, prospective study aimed at determining the maximum tolerated dose (MTD), safety, and tolerability of REYOBIQ in pediatric patients aged 6 to 21 years ...

Modern trials demonstrate excellent outcomes for men with localized prostate cancer treated with radiation therapy. However, some patients experience recurrences, and more than one-third of ...